4.7 Article

Acquisition of anal human papillomavirus (HPV) infection in women: the Hawaii HPV cohort study

期刊

JOURNAL OF INFECTIOUS DISEASES
卷 197, 期 7, 页码 957-966

出版社

OXFORD UNIV PRESS INC
DOI: 10.1086/529207

关键词

-

资金

  1. NCI NIH HHS [CA077318] Funding Source: Medline
  2. NCRR NIH HHS [P20 RR11091] Funding Source: Medline

向作者/读者索取更多资源

Background. The majority of anal cancer is associated with human papillomavirus ( HPV) infection, yet little is known about women's risk of acquisition of anal HPV infection. Methods. Risk factors for the acquisition of anal HPV infection were examined in a longitudinal cohort study of 431 women, via repeated measurement of HPV DNA. Results. Seventy percent of women were positive for anal HPV infection at one or more clinic visits from baseline through a follow-up period that averaged 1.3 years. The incidence of a high-risk ( HR) infection was 19.5 ( 95% confidence interval [ CI], 16.0-23.6) per 1000 woman-months. The most common incident HR HPV types were HPV-53, -52 and -16. The presence of an HR anal HPV infection at baseline increased the risk of an incident anal infection by 65%. Baseline HR cervical HPV infection also predicted the acquisition of an HR anal HPV infection ( odds ratio, 1.81 [ 95% CI, 1.09-3.02]). Nonviral risk factors for acquisition of HR HPV infection included younger age, lower socioeconomic status, greater lifetime number of sexual partners, past use of hormones, and condom use. Conclusions. The results of this study suggest that women's risk of anal HPV infection is as common as their risk of cervical HPV infection.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Reproductive Factors Do Not Influence Survival with Ovarian Cancer

Minh Tung Phung, Aliya Alimujiang, Andrew Berchuck, Hoda Anton-Culver, Joellen M. Schildkraut, Elisa Bandera, Jenny Chang-Claude, Anne Chase, Jennifer Anne Doherty, Bronwyn Grout, Marc T. Goodman, Gillian E. Hanley, Alice W. Lee, Cindy McKinnon Deurloo, Usha Menon, Francesmary Modugno, Paul D. P. Pharoah, Malcolm C. Pike, Jean Richardson, Harvey A. Risch, Weiva Sieh, Kathryn L. Terry, Penelope M. Webb, Nicolas Wentzensen, Anna H. Wu, Celeste Leigh Pearce

Summary: This study found no association between reproductive factors and survival after an ovarian cancer diagnosis.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2022)

Article Immunology

Age-Specific Prevalence of Anal and Cervical Human Papillomavirus Infection and High-Grade Lesions in 11 177 Women by Human Immunodeficiency Virus Status: A Collaborative Pooled Analysis of 26 Studies

Feixue Wei, Ningshao Xia, Rebeca Ocampo, Marc T. Goodman, Nancy A. Hessol, Beatriz Grinsztejn, Ana P. Ortiz, Fanghui Zhao, Erna M. Kojic, Rupert Kaul, Isabelle Heard, Imran O. Morhason-Bello, Anna-Barbara Moscicki, Alexandra de Pokomandy, Joel M. Palefsky, Luana L. S. Rodrigues, Racheal S. Dube Mandishora, Reshmie A. Ramautarsing, Silvia Franceschi, Sheela Godbole, Fernanda K. Tso, Lynette J. Menezes, Chunqing Lin, Gary M. Clifford

Summary: Age-specific shifts in HPV16 prevalence from cervix to anus suggest that HPV infections may persist longer, or occur later in life, in the anus than cervix. This has important implications for using cervical screening results to direct anal cancer prevention.

JOURNAL OF INFECTIOUS DISEASES (2023)

Article Immunology

Incidence and Clearance of Anal Human Papillomavirus Infection in 16 164 Individuals, According to Human Immunodeficiency Virus Status, Sex, and Male Sexuality: An International Pooled Analysis of 34 Longitudinal Studies

Feixue Wei, Marc T. Goodman, Ningshao Xia, Jun Zhang, Anna R. Giuliano, Gypsyamber D'Souza, Nancy A. Hessol, Maarten F. Schim van der Loeff, Jianghong Dai, Karin Neukam, Alexandra de Pokomandy, I. Mary Poynten, Ronald B. Geskus, Joaquin Burgos, Isabelle Etienney, Anna Barbara Moscicki, Maria Gabriella Dona, Maura L. Gillison, Alan G. Nyitray, Rebecca G. Nowak, Evy Yunihastuti, Huachun Zou, Carmen Hidalgo-Tenorio, Nittaya Phanuphak, Jean Michel Molina, Alice M. Schofield, Stephen Kerr, Song Fan, Yong Lu, Jason J. Ong, Admire T. Chikandiwa, Sirinya Teeraananchai, Nicola Squillace, Dorothy J. Wiley, Joel M. Palefsky, Damien Georges, Catharina J. Alberts, Gary M. Clifford

Summary: This study provides a comprehensive analysis of the natural history of anal high-risk HPV infection and identifies differences among different risk groups. These findings are crucial for designing effective anal cancer prevention programs.

CLINICAL INFECTIOUS DISEASES (2023)

Article Nutrition & Dietetics

Coffee consumption and risk of endometrial cancer: a pooled analysis of individual participant data in the Epidemiology of Endometrial Cancer Consortium (E2C2)

Marta Crous-Bou, Mengmeng Du, Marc J. Gunter, Veronica W. Setiawan, Leo J. Schouten, Xiao-ou Shu, Nicolas Wentzensen, Kimberly A. Bertrand, Linda S. Cook, Christine M. Friedenreich, Susan M. Gapstur, Marc T. Goodman, Torukiri I. Ibiebele, Carlo La Vecchia, Fabio Levi, Linda M. Liao, Eva Negri, Susan E. McCann, Kelly O'Connell, Julie R. Palmer, Alpa Patel, Jeanette Ponte, Peggy Reynolds, Carlotta Sacerdote, Rashmi Sinha, Amanda B. Spurdle, Britton Trabert, Piet A. van den Brandt, Penelope M. Webb, Stacey Petruzella, Sara H. Olson, Immaculata De Vivo

Summary: Epidemiologic studies suggest that coffee consumption may be inversely associated with risk of endometrial cancer. Antioxidants and other chemopreventive compounds in coffee may have anticarcinogenic effects. The largest pooled analysis to date further supports the potentially beneficial health effects of coffee consumption in relation to EC.

AMERICAN JOURNAL OF CLINICAL NUTRITION (2022)

Article Oncology

Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study

Ashley Weir, Eun-Young Kang, Nicola S. Meagher, Gregg S. Nelson, Prafull Ghatage, Cheng-Han Lee, Marjorie J. Riggan, Aleksandra Gentry-Maharaj, Andy Ryan, Naveena Singh, Martin Widschwendter, Jennifer Alsop, Michael S. Anglesio, Matthias W. Beckmann, Jessica Berger, Christiani Bisinotto, Jessica Boros, Alison H. Brand, James D. Brenton, Angela Brooks-Wilson, Michael E. Carney, Julie M. Cunningham, Kara L. Cushing-Haugen, Cezary Cybulski, Esther Elishaev, Ramona Erber, Sian Fereday, Anna Fischer, Luis Paz-Ares, Javier Gayarre, Blake C. Gilks, Marcel Grube, Paul R. Harnett, Holly R. Harris, Arndt Hartmann, Alexander Hein, Joy Hendley, Brenda Y. Hernandez, Sabine Heublein, Yajue Huang, Tomasz Huzarski, Anna Jakubowska, Mercedes Jimenez-Linan, Catherine J. Kennedy, Felix K. F. Kommoss, Jennifer M. Koziak, Bernhard Kraemer, Nhu D. Le, Jaime Lesnock, Jenny Lester, Jan Lubinski, Janusz Menkiszak, Britta Ney, Alexander Olawaiye, Sandra Orsulic, Ana Osorio, Luis Robles-Diaz, Matthias Ruebner, Mitul Shah, Raghwa Sharma, Yurii B. Shvetsov, Helen Steed, Aline Talhouk, Sarah E. Taylor, Nadia Traficante, Robert A. Vierkant, Chen Wang, Lynne R. Wilkens, Stacey J. Winham, Javier Benitez, Andrew Berchuck, David D. Bowtell, Francisco J. Candido dos Reis, Linda S. Cook, Anna DeFazio, Jennifer A. Doherty, Peter A. Fasching, Maria J. Garcia, Ellen L. Goode, Marc T. Goodman, Jacek Gronwald, David G. Huntsman, Beth Y. Karlan, Stefan Kommoss, Francesmary Modugno, Joellen M. Schildkraut, Hans-Peter Sinn, Annette Staebler, Linda E. Kelemen, Caroline E. Ford, Usha Menon, Paul D. P. Pharoah, Martin Koebel, Susan J. Ramus, D. Bowtell, A. DeFazio, N. Traficante, S. Fereday, A. Brand, P. Harnett, R. Sharma

Summary: Recently, a study found a positive correlation between protein expression of FOXJ1 and the 5-year survival rate of patients with tubo-ovarian high-grade serous carcinoma (HGSC). However, protein expression of GMNN was not significantly associated with patient survival. This study provides preliminary evidence for the prognostic value of FOXJ1 in HGSC and validates the prior mRNA-based prognostic association through immunohistochemistry.

BRITISH JOURNAL OF CANCER (2023)

Article Oncology

Dietary omega-3 fatty acids and endometrial cancer risk in the Epidemiology of Endometrial Cancer Consortium: An individual-participant meta-analysis

Theodore M. Brasky, Erinn M. Hade, David E. Cohn, Alison M. Newton, Stacey Petruzella, Kelli O'Connell, Kimberly A. Bertrand, Linda S. Cook, Immaculata De Vivo, Mengmeng Du, Jo L. Freudenheim, Christine M. Friedenreich, Marc T. Goodman, Jessica Gorzelitz, Torukiri I. Ibiebele, Vittorio Krogh, Linda M. Liao, Loren Lipworth, Lingeng Lu, Susan McCann, Tracy A. O'Mara, Julie R. Palmer, Jeanette Ponte, Anna Prizment, Harvey Risch, Sven Sandin, Leo J. Schouten, Veronica Wendy Setiawan, Xiao-ou Shu, Britton Trabert, Piet A. van den Brandt, Penelope M. Webb, Nicolas Wentzensen, Lynne R. Wilkens, Alicja Wolk, Herbert Yu, Marian L. Neuhouser

Summary: This study analyzed data from 12 prospective cohort studies and found that higher dietary intake of long-chain omega-3 polyunsaturated fatty acids (LCn3PUFA) may increase the risk of endometrial cancer, especially among specific subgroups characterized by body weight and tumor pathology.

GYNECOLOGIC ONCOLOGY (2023)

Article Oncology

Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery

Minh Tung Phung, Penelope M. Webb, Anna DeFazio, Sian Fereday, Alice W. Lee, David D. L. Bowtell, Peter A. Fasching, Ellen L. Goode, Marc T. Goodman, Beth Y. Karlan, Jenny Lester, Keitaro Matsuo, Francesmary Modugno, James D. Brenton, Toon Van Gorp, Paul D. P. Pharoah, Joellen M. Schildkraut, Karen McLean, Rafael Meza, Bhramar Mukherjee, Jean Richardson, Bronwyn Grout, Anne Chase, Cindy McKinnon Deurloo, Kathryn L. Terry, Gillian E. Hanley, Malcolm C. Pike, Andrew Berchuck, Susan J. Ramus, Celeste Leigh Pearce, Ovarian Canc Assoc Consortium

Summary: This study analyzed the association between 12 lifestyle and personal exposures and having residual disease after surgery in patients with high-grade serous ovarian cancer (HGSC). The use of menopausal estrogen-only therapy (ET) was associated with a lower likelihood of having macroscopic residual disease, while parous women who did not breastfeed also had a lower likelihood of residual disease. These factors could potentially be included in risk stratification models for HGSC patients.

GYNECOLOGIC ONCOLOGY (2023)

Article Oncology

Folate Intake and Ovarian Cancer Risk among Women with Endometriosis: A Case-Control Study from the Ovarian Cancer Association Consortium

Kate Gersekowski, Torukiri I. Ibiebele, Jennifer A. Doherty, Holly R. Harris, Marc T. Goodman, Kathryn L. Terry, Anna H. Wu, Elisa V. Bandera, Bo Qin, Jue-Sheng Ong, Jonathan P. Tyrer, Suzanne C. Dixon-Suen, Francesmary Modugno, Harvey A. Risch, Penelope M. Webb

Summary: A pooled analysis of case-control studies suggests that high dietary folate intake may increase the risk of ovarian cancer in women with endometriosis. Further research is needed to explore the potential cancer-promoting effects of folate in this population.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2023)

Article Oncology

Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

Anil K. Chaturvedi, Eric A. Engels, Ruth M. Pfeiffer, Nicolas Wentzensen, William F. Anderson, Philip S. Rosenberg

Summary: Increases in the incidence and survival of oropharyngeal cancers in the United States since 1984 are attributed to HPV infection. This study examined 271 oropharyngeal cancer patients and found that HPV-positive patients had a significantly longer survival period. The incidence of HPV-positive oropharyngeal cancers is expected to exceed that of cervical cancers by 2020.

JOURNAL OF CLINICAL ONCOLOGY (2023)

Article Medicine, General & Internal

Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic Susceptibility

Lauren M. Hurwitz, Penelope M. Webb, Susan J. Jordan, Jennifer A. Doherty, Holly R. Harris, Marc T. Goodman, Yurii B. Shvetsov, Francesmary Modugno, Kirsten B. Moysich, Joellen M. Schildkraut, Andrew Berchuck, Hoda Anton-Culver, Argyrios Ziogas, Usha Menon, Susan J. Ramus, Anna H. Wu, Celeste Leigh Pearce, Nicolas Wentzensen, Shelley S. Tworoger, Paul D. P. Pharoah, Britton Trabert

Summary: Frequent aspirin use is associated with reduced ovarian cancer risk, and genetic factors do not appear to modify this association according to a study. The findings suggest that aspirin use may be effective in preventing ovarian cancer regardless of genetic susceptibility.

JAMA NETWORK OPEN (2023)

Article Pathology

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study

Martin Kobel, Eun-Young Kang, Ashley Weir, Peter F. Rambau, Cheng-Han Lee, Gregg S. Nelson, Prafull Ghatage, Nicola S. Meagher, Marjorie J. Riggan, Jennifer Alsop, Michael S. Anglesio, Matthias W. Beckmann, Christiani Bisinotto, Michelle Boisen, Jessica Boros, Alison H. Brand, Angela Brooks-Wilson, Michael E. Carney, Penny Coulson, Madeleine Courtney-Brooks, Kara L. Cushing-Haugen, Cezary Cybulski, Suha Deen, Mona A. El-Bahrawy, Esther Elishaev, Ramona Erber, Sian Fereday, Anna Fischer, Simon A. Gayther, Arantzazu Barquin-Garcia, Aleksandra Gentry-Maharaj, C. Blake Gilks, Helena Gronwald, Marcel Grube, Paul R. Harnett, Holly R. Harris, Andreas D. Hartkopf, Arndt Hartmann, Alexander Hein, Joy Hendley, Brenda Y. Hernandez, Yajue Huang, Anna Jakubowska, Mercedes Jimenez-Linan, Michael E. Jones, Catherine J. Kennedy, Tomasz Kluz, Jennifer M. Koziak, Jaime Lesnock, Jenny Lester, Jan Lubinski, Teri A. Longacre, Maria Lycke, Constantina Mateoiu, Bryan M. McCauley, Valerie McGuire, Britta Ney, Alexander Olawaiye, Sandra Orsulic, Ana Osorio, Luis Paz-Ares, Teresa Ramon Y Cajal, Joseph H. Rothstein, Matthias Ruebner, Minouk J. Schoemaker, Mitul Shah, Raghwa Sharma, Mark E. Sherman, Yurii B. Shvetsov, Naveena Singh, Helen Steed, Sarah J. Storr, Aline Talhouk, Nadia Traficante, Chen Wang, Alice S. Whittemore, Martin Widschwendter, Lynne R. Wilkens, Stacey J. Winham, Javier Benitez, Andrew Berchuck, David D. Bowtell, Francisco J. Candido dos Reis, Ian Campbell, Linda S. Cook, Anna DeFazio, Jennifer A. Doherty, Peter A. Fasching, Renee T. Fortner, Maria J. Garcia, Marc T. Goodman, Ellen L. Goode, Jacek Gronwald, David G. Huntsman, Beth Y. Karlan, Linda E. Kelemen, Stefan Kommoss, Nhu D. Le, Stewart G. Martin, Usha Menon, Francesmary Modugno, Paul D. P. Pharoah, Joellen M. Schildkraut, Weiva Sieh, Annette Staebler, Karin Sundfeldt, Anthony J. Swerdlow, Susan J. Ramus, James D. Brenton

Summary: This study aimed to investigate the association between p53 expression status and survival in women with common ovarian carcinoma histotypes. Abnormal p53 expression was found to be associated with an increased risk of death in endometrioid carcinoma (EC) and clear cell carcinoma (CCC) patients. Furthermore, abnormal p53 expression was also associated with shorter overall survival in patients with EC and CCC.

JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2023)

Article Oncology

Global epidemiologic patterns of oropharyngeal cancer incidence trends

Zachary S. Zumsteg, Michael Luu, Philip S. Rosenberg, Julia K. Elrod, Freddie Bray, Salvatore Vaccarella, Christopher Gay, Diana J. Lu, Michelle M. Chen, Anil K. Chaturvedi, Marc T. Goodman

Summary: The incidence of oropharyngeal cancer is increasing worldwide, with a shift towards older age groups in men and diverse patterns in women.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Article Oncology

Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores

Daniel R. Barnes, Valentina Silvestri, Goska Leslie, Lesley McGuffog, Joe Dennis, Xin Yang, Julian Adlard, Bjarni A. Agnarsson, Munaza Ahmed, Kristiina Aittomaki, Irene L. Andrulis, Adalgeir Arason, Norbert Arnold, Bernd Auber, Jacopo Azzollini, Judith Balmana, Rosa B. Barkardottir, Daniel Barrowdale, Julian Barwell, Muriel Belotti, Javier Benitez, Pascaline Berthet, Susanne E. Boonen, Ake Borg, Aniko Bozsik, Angela F. Brady, Paul Brennan, Carole Brewer, Joan Brunet, Agostino Bucalo, Saundra S. Buys, Trinidad Caldes, Maria A. Caligo, Ian Campbell, Hayley Cassingham, Lise Lotte Christensen, Giulia Cini, Kathleen B. M. Claes, Jackie Cook, Anna Coppa, Laura Cortesi, Giuseppe Damante, Esther Darder, Rosemarie Davidson, Miguel de la Hoya, Kim De Leeneer, Robin de Putter, Jesus Del Valle, Orland Diez, Yuan Chun Ding, Susan M. Domchek, Alan Donaldson, Jacqueline Eason, Ros Eeles, Christoph Engel, D. Gareth Evans, Lidia Feliubadalo, Florentia Fostira, Megan Frone, Debra Frost, David Gallagher, Andrea Gehrig, Sophie Giraud, Gord Glendon, Andrew K. Godwin, David E. Goldgar, Mark H. Greene, Helen Gregory, Eva Gross, Eric Hahnen, Ute Hamann, Thomas V. O. Hansen, Helen Hanson, Julia Hentschel, Judit Horvath, Louise Izatt, Angel Izquierdo, Paul A. James, Ramunas Janavicius, Uffe Birk Jensen, Oskar Th Johannsson, Esther M. John, Gero Kramer, Lone Kroeldrup, Torben A. Kruse, Charlotte Lautrup, Conxi Lazaro, Fabienne Lesueur, Adria Lopez-Fernandez, Phuong L. Mai, Siranoush Manoukian, Zoltan Matrai, Laura Matricardi, Kara N. Maxwell, Noura Mebirouk, Alfons Meindl, Marco Montagna, Alvaro N. Monteiro, Patrick J. Morrison, Taru A. Muranen, Alex Murray, Katherine L. Nathanson, Susan L. Neuhausen, Heli Nevanlinna, Tu Nguyen-Dumont, Dieter Niederacher, Edith Olah, Olufunmilayo Olopade, Domenico Palli, Michael T. Parsons, Inge Sokilde Pedersen, Bernard Peissel, Pedro Perez-Segura, Paolo Peterlongo, Annabeth H. Petersen, Pedro Pinto, Mary E. Porteous, Caroline Pottinger, Miquel Angel Pujana, Paolo Radice, Juliane Ramser, Johanna Rantala, Mark Robson, Mark T. Rogers, Karina Ronlund, Andreas Rump, Ana Maria Sanchez de Abajo, Payal D. Shah, Saba Sharif, Lucy E. Side, Christian F. Singer, Zsofia Stadler, Linda Steele, Dominique Stoppa-Lyonnet, Christian Sutter, Yen Yen Tan, Manuel R. Teixeira, Alex Teule, Darcy L. Thull, Marc Tischkowitz, Amanda E. Toland, Stefania Tommasi, Angela Toss, Alison H. Trainer, Vishakha Tripathi, Virginia Valentini, Christi J. van Asperen, Marta Venturelli, Alessandra Viel, Joseph Vijai, Lisa Walker, Shan Wang-Gohrke, Barbara Wappenschmidt, Anna Whaite, Ines Zanna, Kenneth Offit, Mads Thomassen, Fergus J. Couch, Rita K. Schmutzler, Jacques Simard, Douglas F. Easton, Georgia Chenevix-Trench, Antonis C. Antoniou, Laura Ottini

Summary: The study assessed the associations of polygenic risk scores with breast and prostate cancer risks for male BRCA1 and BRCA2 carriers, finding strong associations between the risk scores and the respective cancer risks. The estimated breast cancer odds ratios were larger after adjusting for family history of female relative breast cancer.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2022)

暂无数据